Key facts
- This page summarizes Michael S. Urdea's Form 4 filing for PRESSURE BIOSCIENCES INC.
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Oct 2023, 17:10.
Michael S. Urdea - 18 Oct 2023 Form 4 Insider Report for PRESSURE BIOSCIENCES INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 18 Oct 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Oct 2023, 17:10:19 UTC
- Prior SEC filing
- 31 May 2023
- Next SEC filing
- 24 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael S Urdea
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael S. Urdea filed Form 4 for PRESSURE BIOSCIENCES INC on 25 Oct 2023.
Change
- Previous filing in this sequence was filed on 31 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PBIO
transaction
Derivative
Non-Qualified Stock Option
Award
- Transaction value
- $0
- Shares
- +73,802
- Change %
- +39%
- Price
- $0.000000
- Shares after
- 261,482
- Date
- 18 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 73,802
- Exercise price
- $0.2500
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
73,802 from 2021 Plan.
Footnote F2
Vest equal over twelve (12) months.